Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lipton

Showing results (111-120 of 832) with videos related to

Pageof 84
Sort By:
Neuron|April 16, 1998
Aberrant RNA splicing in sporadic amyotrophic lateral sclerosisG Bai, S A Lipton
Oncology (Williston Park, N.Y.)|December 3, 1998
Use of bisphosphonates in patients with metastatic bone diseaseJ R Berenson, A Lipton
Neuron|July 18, 2009
According to GOSPEL: filling in the GAP(DH) of NO-mediated neurotoxicityTomohiro Nakamura, Stuart A Lipton
Medical Education|March 1, 1978
Examination design and preparationA Lipton, G J Huxham
The New England Journal of Medicine|December 2, 1993
Iron deficiency in childrenM Pless, S A Lipton
Neuroscience Letters|May 25, 1992
L-homocysteic acid selectively activates N-methyl-D-aspartate receptors of rat retinal ganglion cellsD Zhang, S A Lipton
Nature|August 9, 2001
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascadesM Digicaylioglu, S A Lipton
Annual Review of Medicine|March 12, 1999
Bisphosphonates in the treatment of malignant bone diseaseJ R Berenson, A Lipton
The Journal of Neuropsychiatry and Clinical Neurosciences|August 22, 2001
Emergent neuroleptic hypersensitivity as a herald of presenile dementiaM F Mendez, A Lipton
British Journal of Medical Education|September 1, 1970
Comparison of multiple-choice and essay testing in preclinical physiologyA Lipton, G J Huxham
Pageof 84

Showing results (111-120 of 832) with videos related to

Sort By:
Pageof 84
Neuron|April 16, 1998
Aberrant RNA splicing in sporadic amyotrophic lateral sclerosisG Bai, S A Lipton
Oncology (Williston Park, N.Y.)|December 3, 1998
Use of bisphosphonates in patients with metastatic bone diseaseJ R Berenson, A Lipton
Neuron|July 18, 2009
According to GOSPEL: filling in the GAP(DH) of NO-mediated neurotoxicityTomohiro Nakamura, Stuart A Lipton
Medical Education|March 1, 1978
Examination design and preparationA Lipton, G J Huxham
The New England Journal of Medicine|December 2, 1993
Iron deficiency in childrenM Pless, S A Lipton
Neuroscience Letters|May 25, 1992
L-homocysteic acid selectively activates N-methyl-D-aspartate receptors of rat retinal ganglion cellsD Zhang, S A Lipton
Nature|August 9, 2001
Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascadesM Digicaylioglu, S A Lipton
Annual Review of Medicine|March 12, 1999
Bisphosphonates in the treatment of malignant bone diseaseJ R Berenson, A Lipton
The Journal of Neuropsychiatry and Clinical Neurosciences|August 22, 2001
Emergent neuroleptic hypersensitivity as a herald of presenile dementiaM F Mendez, A Lipton
British Journal of Medical Education|September 1, 1970
Comparison of multiple-choice and essay testing in preclinical physiologyA Lipton, G J Huxham
Pageof 84